Obstructive sleep apnoea inhibits the recovery of left ventricular function in patients with acute myocardial infarction

European Heart Journal

Volumn 27, Issue 19, 2006, Pages 2317-2322

  Nakashima, Hiroshi ^a   Katayama, Toshiro ^a   Takagi, Chisa ^a   Amenomori, Kentarou ^a   Ishizaki, Masahiko ^a   Honda, Yukiharu ^a   Suzuki, Shin ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Acute myocardial infarction; Obstructive sleep apnea; Primary percutaneus coronary intervention

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; APNEA; ARTICLE; BRAIN VENTRICULOGRAPHY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DELTA RHYTHM; FEMALE; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE WALL MOTION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HEART VOLUME; HUMAN; MALE; MULTIPLE REGRESSION; PERCUTANEOUS CORONARY INTERVENTION; POLYSOMNOGRAPHY; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; SYSTOLE;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; POLYSOMNOGRAPHY; RECOVERY OF FUNCTION; SLEEP APNEA, OBSTRUCTIVE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33749021087     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehl219     Document Type: Article

References (35)

1. Peker Y, Hedner J, Kraiczi H, Loth S. Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 2000;162:81-86.
2. Hung J, Whitford EG, Parsons RW, Hillman DR. Association of sleep apnoea with myocardial infarction in men. Lancet 1990;336:261-264.
3. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier Nieto F, O'Connor GT, Boland LL, Schwartz JE, Samet JM. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001;163:19-25.
4. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365:1046-1053.
5. Weiss JW, Remsburg S, Garpestad E, Ringler J, Sparrow D, Parker JA. Hemodynamic consequences of obstructive sleep apnoea. Sleep 1996;19:388-397.
6. Tkacova R, Rankin F, Fitzgerald FS, Floras JS, Bradley TD. Effects of continuous positive airway pressure on obstructive sleep apnoea and left ventricular after-load in patients with heart failure. Circulation 1998;98:2269-2275.
7. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnoea. J Clin Invest 1995;96:1897-1904.
8. Peled N, Abinader EG, Pillar G, Sharif D, Lavie P. Nocturnal ischaemic events in patients with obstructive sleep apnoea syndrome and ischaemic heart disease: effects of continuous positive air pressure treatment. J Am Coll Cardiol 1999;34:1744-1749.
9. Franklin KA, Nilsson JB, Sahlin C, Naslund U. Sleep apnoea and nocturnal angina. Lancet 1995;29:1085-1087.
10. Javaheri S, Parker TJ, Liming JD, Corbett WS, Nishiyama H, Wexler L, Roselle GA. Sleep apnoea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations Circulation 1998;97:2154-2159.
11. Sin DD, Fitzgerald F, Parker JD, Newton G, Floras JS, Bradley TD. Risk factors for central and obstructive sleep apnoea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999;160:1101-1106.
12. Laaban JP, Pascal-Sebaoun S, Bloch E, Orvoen-Frija E, Oppert JM, Huchon G. Left ventricular systolic dysfunction in patients with obstructive sleep apnoea syndrome. Chest 2002;122:1133-1138.
13. Kaneko Y, Floras JS, Usui K, Plante J, Tkacova R, Kubo T, Ando S, Bradley TD. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnoea. N Engl J Med 2003;348:1233-1241.
14. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-322.
15. Stone GW, Grines CL, Browne KF, Marco J, Rothbaum D, O'Keefe J, Hartzler GO, Overlie P, Donohue B, Chelliah N, Vlietstra R, Puchrowicz-Ochocki S, O'Neill WW. Influence of acute myocardial infarction location on in-hospital and late outcome after primary percutaneous transluminal coronary angioplasty versus tissue plasminogen activator therapy. Am J Cardiol 1996;78:19-25.
16. Cohen M, Rentrop KP. Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: a prospective study. Circulation 1986;74:469-476.
17. Piana RN, Paik GY, Moscucci M, Cohen DJ, Gibson CM, Kugelmass AD, Carrozza JP Jr, Kuntz RE, Baim DS. Incidence and treatment of 'no-reflow' after percutaneous coronary intervention. Circulation 1994;89:2514-2518.
18. Dodge HT, Sandler H, Ballew DW, Lord JD Jr. The use of biplane angiocardigraphy for the measurement of left ventricular volume in man. Am Heart J 1960;60:762-776.
19. Sheehan FH, Schofer J, Mathey DG, Kellett MA, Smith H, Bolson EL, Dodge HT. Measurement of regional wall motion from biplane contrast ventriculograms: a comparison of the 30 degree right anterior oblique and 60 degree left anterior oblique projections in patients with acute myocardial infarction. Circulation 1986;74:796-804.
20. Halkin A, Stone GW, Grines CL, Cox DA, Rutherford BD, Esente P, Meils CM, Albertsson P, Farah A, Tcheng JE, Lansky AJ, Mehran R. Prognostic implications of creatine kinase elevation after primary percutaneous coronary intervention for acute myocardial infarction. J Am Coll Cardiol 2006;47:951-961.
21. Sheiban I, Fragasso G, Rosano GM, Dharmadhikari A, Tzifos V, Pagnotta P, Chierchia SL, Trevi G. Time course and determinants of left ventricular function recovery after primary angioplasty in patients with acute myocardial infarction. J Am Coll Cardiol 2001;38:464-471. (revised manuscript, Methods, page 2, line 4-page 3, line 2).
22. Lundergan CF, Ross AM, McCarthy WF, Reiner JS, Boyle D, Fink C, Califf RM, Topol EJ, Simoons ML, Van Den Brand M, Van de Werf F, Coyne KS, GUSTO-I Angiographic Investigators. Predictors of left ventricular function after acute myocardial infarction: effects of time to treatment, patency, and body mass index: the GUSTO-I angiographic experience. Am Heart J 2001;142:43-50.
23. Opie LH. Reperfusion injury and its pharmacologic modification. Circulation 1989;80:1049-1062.
24. Bolli R. Basic and clinical aspects of myocardial stunning. Prog Cardiovasc Dis 1998;40:477-516.
25. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 1994;94:1621-1628.
26. Christou K, Markoulis N, Moulas AN, Pastaka C, Gourgoulianis KI. Reactive oxygen metabolites (ROMs) as an index of oxidative stress in obstructive sleep apnoea patients. Sleep Breath 2003;7:105-110.
27. Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnoea patients. Am J Respir Crit Care Med 2002;165:934-939.
28. Christou K, Moulas AN, Pastaka C, Gourgoulianis KI. Antioxidant capacity in obstructive sleep apnoea patients. Sleep Med 2003;4:225-228.
29. Mahler F, Ross J Jr, O'Rourke RA, Covell JW. Effects of changes in preload, afterload and inotropic state on ejection and isovolumic phase measures of contractility in the conscious dog. Am J Cardiol 1975;35:626-634.
30. Ross J Jr. Afterload mismatch and preload reserve: a conceptual framework for the analysis of ventricular function. Prog Cardiovasc Dis 1976;18:255-264.
31. Shivalkar B, Van de Heyning C, Kerremans M, Rinkevich D, Verbraecken J, De Backer W, Vrints C. Obstructive sleep apnoea syndrome: more insights on structural and functional cardiac alterations, and the effects of treatment with continuous positive airway pressure. J Am Coll Cardiol 2006;47:1433-1439.
32. Kernis SJ, Harjai KJ, Stone GW, Grines LL, Boura JA, O'Neill WW, Grines CL. Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty? J Am Coll Cardiol 2004;43:1773-1779.
33. Latini R, Tognoni G, Maggioni AP, Baigent C, Braunwald E, Chen ZM, Collins R, Flather M, Franzosi MG, Kjekshus J, Kober L, Liu LS, Peto R, Pfeffer M, Pizzetti F, Santoro E, Sleight P, Swedberg K, Tavazzi L, Wang W, Yusuf S. Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collaborative Group. J Am Coll Cardiol 2000;35:1801-1807.
34. Solomon SD, Glynn RJ, Greaves S, Ajani U, Rouleau JL, Menapace F, Arnold JM, Hennekens C, Pfeffer MA. Recovery of ventricular function after myocardial infarction in the reperfusion era: the healing and early after-load reducing therapy study. Ann Intern Med 2001;134:451-458.
35. Li KK, Kushida C, Powell NB, Riley RW, Guilleminault C. Obstructive sleep apnoea syndrome: a comparison between Far-East Asian and white men. Laryngoscope 2000;110:1689-1693.